China eases cross-border data transfer restrictions for financial institutions; Trade war prompts plan to open up service sector; and new law firm anti-money laundering regulations to align with international standards
April 25, 2025
Foreign Direct Investment
Transfer of data across borders presents a particular compliance challenge for companies in China. Xiangxiang Ma, a partner of Anjie Broad Law Firm, analyses a new document which brings welcome practical clarification to this area
April 24, 2025NMPA details procedures for applying for pharma data protection / Issued: 2025-03-19
April 17, 2025China proposes different data protection periods for three categories of drugs / Issued: 2025-03-19
April 17, 2025The Cyberspace Administration clarifies its approach to the export of personal and important information out of China; UK weighs whether to include China in foreign influence disclosure rules; and Burberry wins online trademark infringement suit.
April 17, 2025China to block Chinese firms from investing in the U.S. amid tariff war; Shenzhen launches incentives for foreign-owned hospitals following national legislation; and U.S. companies plan continuous engagement with China
April 11, 2025China specifies penalties for a failure to implement sanction countering measures / CLP Reference: 1300/25.03.23 ; Promulgated: 2025-03-23 ; Effective: 2025-03-23
April 08, 2025State Council restricts provision of evidence outside of mainland China for IP cases / CLP Reference: 5100/25.03.13 ; Promulgated: 2025-03-13 ; Effective: 2025-05-01
April 08, 2025Total asset requirement is relaxed for Hong Kong and Macao insurance company investments / CLP Reference: 3910/25.02.26 ; Issued: 2025-02-26 ; Effective: 2025-03-01
April 08, 2025China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate facial recognition technology; and UBS becomes the 5th wholly foreign-owned securities firm in China.
April 03, 2025
